Search clinical trials for: DPP IV Inhibitor
Total 79839 results
-
Mayo ClinicRecruiting
-
Beni-Suef UniversityFaculty of Medicine, Minia University; Clinical Pharmacy Department, Faculty...Not yet recruiting
-
Thermosome GmbHRecruitingSarcoma, Soft TissueGermany
-
MTI UniversityNational Institute of Diabetes and Endocrinology, EgyptRecruitingType 2 Diabetes MellitusEgypt
-
Peking University People's HospitalPeking University First Hospital; Jiangsu Province Geriatric InstituteRecruitingDiabetes Mellitus, Type 2 | Severe Insulin Deficient DiabetesChina
-
LG ChemNot yet recruitingHealthy Volunteers
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of PennsylvaniaRecruitingHeart Failure | Type2 Diabetes | Genetics DiseaseUnited States
-
Medical University of ViennaRecruitingPupillary Reflex ImpairedAustria
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
SINA Health Education and Welfare TrustHorizon Pharmaceutical Pvt LtdCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | EmpagliflozinPakistan
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | NASHEgypt
-
Qianfoshan HospitalActive, not recruiting
-
Sadat City UniversityActive, not recruitingMajor Depressive DisorderEgypt
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedMyocardial Infarction | Heart Failure | Ischemic Stroke | Type2 Diabetes | Cardiovascular Death | All-Cause MortalityCanada
-
TakedaCompleted
-
TakedaCompleted
-
Weill Medical College of Cornell UniversityPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusSweden
-
Ain Shams UniversityCompleted
-
Celltrion Pharm, Inc.Active, not recruiting
-
University Hospital MuensterCompletedSystemic Inflammatory Response SyndromeGermany
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Johns Hopkins UniversityTerminated
-
Oregon Health and Science UniversitySuspended
-
Erasme University HospitalTerminatedType 2 Diabetes | Pancreas | IncretinomimeticsBelgium
-
The Catholic University of KoreaCompletedDiabetes MellitusKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Chungbuk National University HospitalCompleted
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
GRADE Study GroupBristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompletedType 2 Diabetes | Comparative Effectiveness of Glycemia-lowering MedicationsUnited States
-
Vanderbilt UniversityCompletedHypertension | Type 2 Diabetes MellitusUnited States
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
Metabolic Research UnitEnrolling by invitation